Fallopian Tube Cancer

Common Name(s)

Fallopian Tube Cancer

Fallopian tube cancer is a very rare form of cancer with only 1,500 to 2,000 cases reported each year in the United States. However, a number of cancers start in other parts of the body and spread to the fallopian tubes, called secondary fallopian tube cancers. Some symptoms include abnormal vaginal bleeding, abnormal vaginal discharge, abdominal pain, and feeling a mass in the abdomen (belly) or pelvis. A female pelvic exam can assist in the diagnosis of this condition by evaluating the size and shape of the uterus, vagina, ovaries, fallopian tubes, bladder and rectum. A blood test can also be performed to check the levels of a certain protein called CA125, which may be used to diagnose fallopian tube cancer. Treatment usually involves surgery and chemotherapy, depending on age, desire to have children, and the type and stage of the tumor.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Fallopian Tube Cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Fallopian Tube Cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Fallopian Tube Cancer" returned 54 free, full-text research articles on human participants. First 3 results:

A Phase II clinical trial of pegylated liposomal doxorubicin and carboplatin in Japanese patients with platinum-sensitive recurrent ovarian, fallopian tube or primary peritoneal cancer.
 

Author(s): Toru Nakanishi, Daisuke Aoki, Yoh Watanabe, Yuichi Ando, Naoki Tomotsugu, Yuji Sato, Toshiaki Saito

Journal: Jpn. J. Clin. Oncol.. 2015 May;45(5):422-6.

 

This single-arm Phase II trial was designed to assess the safety and efficacy of pegylated liposomal doxorubicin and carboplatin combination chemotherapy in patients with platinum-sensitive recurrent ovarian cancer.

Last Updated: 29 Apr 2015

Go To URL
A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer.
 

Author(s): Yun Wang, Jørn Herrstedt, Hanne Havsteen, Rene DePoint Christensen, Mansoor Raza Mirza, Bente Lund, Johanna Maenpaa, Gunnar Kristensen

Journal:

 

In patients with ovarian cancer relapsing at least 6 months after end of primary treatment, the addition of paclitaxel to platinum treatment has been shown to improve survival but at the cost of significant neuropathy. In the first line setting, the carboplatin-docetaxel combination ...

Last Updated: 5 Jan 2015

Go To URL
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.
 

Author(s): Rudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, Jerrold B Teitcher, Svetlana Mironov, Revathy B Iyer, Qin Zhou, Alexia Iasonos, Harold Paul, Masayoshi Hosaka, Carol A Aghajanian, Mario M Leitao, Ginger J Gardner, Nadeem R Abu-Rustum, Yukio Sonoda, Douglas A Levine, Hedvig Hricak, Dennis S Chi

Journal: Gynecol. Oncol.. 2014 Sep;134(3):455-61.

 

To assess the ability of preoperative computed tomography (CT) scan of the abdomen/pelvis and serum CA-125 to predict suboptimal (>1cm residual disease) primary cytoreduction in advanced ovarian, fallopian tube, and peritoneal cancer.

Last Updated: 9 Sep 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Fallopian Tube Cancer" returned 4 free, full-text review articles on human participants. First 3 results:

Primary fallopian tube cancer: domestic data and up-to-date review.
 

Author(s): Huann-Cheng Horng, Sen-Wen Teng, Ben-Shian Huang, Hsu-Dong Sun, Ming-Shyen Yen, Peng-Hui Wang, Kuan-Hao Tsui, Kuo-Chang Wen, Yi-Jen Chen, Chi-Mu Chuang, Hsiang-Tai Chao, Wen-Hsun Chang

Journal: Taiwan J Obstet Gynecol. 2014 Sep;53(3):287-92.

 

Primary fallopian tube carcinoma (PFTC) is a rare gynecological malignancy with the following characteristics: its preoperative diagnosis is easy to miss or delay because of a lack of specific symptoms and signs; it is difficult to distinguish from serous epithelial ovarian cancer ...

Last Updated: 7 Oct 2014

Go To URL
The role of the fallopian tube in the origin of ovarian cancer.
 

Author(s): Britt K Erickson, Michael G Conner, Charles N Landen

Journal: Am. J. Obstet. Gynecol.. 2013 Nov;209(5):409-14.

 

Advanced cases of epithelial ovarian, primary peritoneal, and primary tubal malignancies have a relatively poor prognosis and collectively remain the most deadly of all gynecologic malignancies. Although traditionally thought of as one disease process, ongoing research suggests that ...

Last Updated: 11 Nov 2013

Go To URL
The molecular fingerprint of high grade serous ovarian cancer reflects its fallopian tube origin.
 

Author(s): Mirjana Kessler, Christina Fotopoulou, Thomas Meyer

Journal:

 

High grade serous ovarian cancer (HGSC), the most lethal and frequent type of epithelial ovarian cancer (EOC), has poor long term prognosis due to a combination of factors: late detection, great metastatic potential and the capacity to develop resistance to available therapeutic drugs. ...

Last Updated: 26 Mar 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
 

Status: Not yet recruiting

Condition Summary: Ovarian Epithelial Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer

 

Last Updated: 30 Apr 2015

Go to URL
Carboplatin and Gemcitabine Hydrochloride With or Without ATR Kinase Inhibitor VX-970 in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
 

Status: Not yet recruiting

Condition Summary: High Grade Ovarian Serous Adenocarcinoma; Ovarian Endometrioid Tumor; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Stage IV Fallopian Tube Cancer; Stage IV Ovarian Cancer; Stage IV Primary Peritoneal Cancer

 

Last Updated: 9 Dec 2015

Go to URL
PH2 Study of IMGN853 vs Investigator's Choice of Chemo in Adults With FRa+ Adv. EOC, Primary Peritoneal or Primary Fallopian Tube Cancer
 

Status: Recruiting

Condition Summary: Epithelial Ovarian Cancer; Primary Peritoneal Carcinoma; Primary Fallopian Tube Cancer

 

Last Updated: 1 Feb 2016

Go to URL